[1]
Shahriar, S. et al. 2020. Tablet Splitting Performance Evaluation of Losartan Potassium and Olmesartan Medoxomil IR Tablets Marketed in Bangladesh. Bangladesh Pharmaceutical Journal. 23, 2 (Jul. 2020), 146–154. DOI:https://doi.org/10.3329/bpj.v23i2.48335.